ATI RN
Safety Pharmacology Across the Lifespan ATI Quizlet Questions
Question 1 of 5
Most local anesthetics can cause:
Correct Answer: D
Rationale: In the context of safety pharmacology, local anesthetics are known to have systemic effects beyond their primary mechanism of action. The correct answer, "D) All of the above," is accurate because most local anesthetics can indeed cause a range of cardiovascular effects, including depression of abnormal cardiac pacemaker activity, excitability, conduction, depression of the strength of cardiac contraction, and even cardiovascular collapse. Option A, "Depression of abnormal cardiac pacemaker activity, excitability, conduction," is a potential effect of local anesthetics due to their ability to interfere with the normal electrical activity of the heart. This can lead to arrhythmias and conduction disturbances. Option B, "Depression of the strength of cardiac contraction," is also a possible consequence of local anesthetics as they can depress myocardial contractility, leading to decreased cardiac output and potential cardiovascular compromise. Option C, "Cardiovascular collapse," represents a severe manifestation of the cardiovascular effects of local anesthetics, which can result from a combination of the previously mentioned mechanisms and potentially lead to a life-threatening situation. In an educational context, understanding the systemic effects of medications, such as local anesthetics, is crucial for healthcare professionals to anticipate and manage potential complications. By grasping the cardiovascular implications of these drugs, practitioners can make informed decisions regarding their use, monitor patients effectively, and intervene promptly if adverse reactions occur. This knowledge is vital for ensuring patient safety and optimizing care across the lifespan.
Question 2 of 5
Indicate cholinesterase activator:
Correct Answer: A
Rationale: In the context of safety pharmacology, understanding cholinesterase activators is crucial as they play a significant role in various physiological processes. In this question, the correct answer is A) Pralidoxime. Pralidoxime is a cholinesterase reactivator used in cases of organophosphate poisoning to reverse the toxic effects by reactivating inhibited cholinesterase enzymes. Option B) Edrophonium is a cholinesterase inhibitor used to diagnose myasthenia gravis by temporarily increasing the availability of acetylcholine at the neuromuscular junction. Option C) Pilocarpine is a cholinergic agonist used to treat conditions like glaucoma and dry mouth by stimulating muscarinic receptors. Option D) Isoflurophate is an irreversible cholinesterase inhibitor used in ophthalmology to constrict the pupil for diagnostic purposes. Educationally, understanding the differences between cholinesterase activators and inhibitors is crucial for safe pharmacological practice. By knowing the specific actions of each drug, healthcare professionals can make informed decisions when managing patients with conditions related to cholinergic systems.
Question 3 of 5
The toxic effects of a large dose of nicotine include all of the following EXCEPT:
Correct Answer: A
Rationale: The correct answer is A) Hypotension and bradycardia. Nicotine, when taken in large doses, acts as a stimulant initially, leading to hypertension and tachycardia. However, as the dose increases, it can cause central nervous system depression, leading to hypotension and bradycardia. Option B) Convulsions, coma, and respiratory arrest are potential toxic effects of a large dose of nicotine due to its impact on the central nervous system. Option C) Skeletal muscle depolarization blockade and respiratory paralysis can occur with nicotine poisoning, affecting neuromuscular transmission and leading to muscle weakness and respiratory failure. Option D) Hypertension and cardiac arrhythmias are early effects of nicotine toxicity due to its stimulant properties on the cardiovascular system. Educational context: Understanding the toxic effects of nicotine is crucial for healthcare professionals, especially in cases of accidental ingestion or intentional overdose. By knowing the range of symptoms associated with nicotine toxicity, healthcare providers can provide appropriate treatment and interventions to manage the effects and prevent further harm.
Question 4 of 5
Atropine is highly selective for:
Correct Answer: D
Rationale: Atropine is a medication that acts as a non-selective antagonist of muscarinic acetylcholine receptors. Therefore, the correct answer is D) All of the above because atropine is not highly selective for any specific muscarinic receptor subtype. It blocks all five muscarinic receptor subtypes (M₁, M₂, M₃, M₄, M₅) to varying degrees. Option A) M₁ receptor subtype, Option B) M₂ receptor subtype, and Option C) M₃ receptor subtype are incorrect because atropine does not show high selectivity for any specific muscarinic receptor subtype. Understanding the non-selective nature of atropine's action is crucial in the context of safety pharmacology as it helps healthcare providers anticipate and manage the broad range of effects that atropine can have on different organ systems across the lifespan. In clinical practice, atropine is commonly used to treat bradycardia, organophosphate poisoning, and to dilate the pupils during eye examinations. Knowing that atropine acts on multiple muscarinic receptor subtypes can guide healthcare professionals in assessing potential side effects and interactions when administering this medication to patients of different age groups.
Question 5 of 5
Compared with atropine, scopolamine has all of the following properties EXCEPT:
Correct Answer: B
Rationale: In this question, the correct answer is B) Less potent in decreasing bronchial, salivary, and sweat gland secretion. Scopolamine and atropine are both anticholinergic drugs, but they have differences in their pharmacological properties. Scopolamine is more potent in producing mydriasis and cycloplegia and has a more marked central effect compared to atropine. Additionally, scopolamine has lower effects on the heart, bronchial muscle, and intestines compared to atropine. Atropine, on the other hand, is known for its potent effects on decreasing bronchial, salivary, and sweat gland secretion. This property is crucial in its clinical use for conditions like asthma, excessive salivation, and sweating. In an educational context, understanding the specific pharmacological properties of drugs like atropine and scopolamine is essential for healthcare professionals, especially in fields like pharmacology and nursing. Knowing these differences helps in making informed decisions about drug selection and understanding potential side effects and therapeutic uses.